Match!
Giuliano Tocci
Sapienza University of Rome
243Publications
24H-index
2,055Citations
Publications 243
Newest
Published on Nov 1, 2018in International Journal of Cardiology3.47
Vivianne Presta4
Estimated H-index: 4
(Sapienza University of Rome),
Giuliano Tocci24
Estimated H-index: 24
(Sapienza University of Rome),
Massimo Volpe65
Estimated H-index: 65
(Sapienza University of Rome)
Published on Apr 1, 2019in International Journal of Cardiology3.47
Massimo Volpe65
Estimated H-index: 65
(Sapienza University of Rome),
Giovanna Gallo3
Estimated H-index: 3
(Sapienza University of Rome),
Giuliano Tocci24
Estimated H-index: 24
(Sapienza University of Rome)
Abstract The 2018 European and 2017 American guidelines recommend to start antihypertensive treatment with combinations of two or more drugs in most hypertensive patients, as a consequence of the suggested more ambitious blood pressure (BP) targets (systolic BP between 130 and 120 mmHg in most patients, diastolic BP between 80 and 70 mmHg). Monotherapy, however, is still suggested as first choice in some specific classes of patients. In this article, we analyze the subgroups of hypertensive pati...
Published on May 13, 2019in Internal and Emergency Medicine2.33
Vivianne Presta4
Estimated H-index: 4
(Sapienza University of Rome),
Barbara Citoni3
Estimated H-index: 3
(Sapienza University of Rome),
Giuliano Tocci24
Estimated H-index: 24
(Sapienza University of Rome)
Published on Jul 1, 2019in International Journal of Cardiology3.47
Salvatore Raffa19
Estimated H-index: 19
(Sapienza University of Rome),
Xiao Lan Diana Chin + 12 AuthorsLeonardo Schirone4
Estimated H-index: 4
(Sapienza University of Rome)
Abstract Background Deficiency of NADH dehydrogenase [ubiquinone], the mitochondrial complex I, represents an emerging mechanism of cardiovascular diseases. Ndufc2, a subunit of mitochondrial complex I, is involved in stroke development. We aimed to gain some insights on the role of Ndufc2 into acute coronary syndrome (ACS) through the assessment of its gene expression, along with that of anti-oxidant proteins and of mitochondrial function parameters, in circulating mononuclear cells (PBMCs) of ...
Published on Jun 6, 2019
Massimo Volpe1
Estimated H-index: 1
,
Giovanna Gallo3
Estimated H-index: 3
,
Giuliano Tocci24
Estimated H-index: 24
Published on Jun 1, 2019in Atherosclerosis4.25
Vivianne Presta4
Estimated H-index: 4
,
Ilaria Figliuzzi3
Estimated H-index: 3
+ 20 AuthorsGiuliano Tocci24
Estimated H-index: 24
Abstract Background and aims Target and intensity of low-density lipoprotein cholesterol (LDL-C) lowering therapy should be tailored according to the individual global cardiovascular (CV) risk. We aimed at retrospectively evaluating real-life LDL-C goal attainment and predictive factors for predefined LDL-C therapeutic goals both in primary and secondary prevention. Methods We collected data from a large cohort of outpatients aged 40–65 years, followed by general practitioners, cardiologists and...
Published on Jan 23, 2018in Critical Reviews in Food Science and Nutrition6.70
Federica Fogacci10
Estimated H-index: 10
(UNIBO: University of Bologna),
Giuliano Tocci24
Estimated H-index: 24
(Sapienza University of Rome)
+ 3 AuthorsArrigo F.G. Cicero43
Estimated H-index: 43
(UNIBO: University of Bologna)
ABSTRACTIntroduction: Results of previous clinical trials evaluating the effect of resveratrol supplementation on blood pressure (BP) are controversial.Purpose: We aimed to assess the impact of resveratrol on BP through systematic review of literature and meta-analysis of available randomized, controlled clinical trials (RCTs).Methods: Literature search included SCOPUS, PubMed-Medline, ISI Web of Science and Google Scholar databases up to 17th October 2017 to identify RCTs investigating the impa...
Published on Apr 1, 2019in European Heart Journal23.24
Camilla Torlasco4
Estimated H-index: 4
(University of Milan),
Camilla Torlasco4
Estimated H-index: 4
(University of Milan)
+ 12 AuthorsNeil Poulter78
Estimated H-index: 78
(Imperial College London)
12345678910